designer drugs

Preferred Label : designer drugs;

MeSH definition : Drugs designed and synthesized, often for illegal street use, by modification of existing drug structures (e.g., amphetamines). Of special interest are MPTP (a reverse ester of meperidine), MDA (3,4-methylenedioxyamphetamine), and MDMA (3,4-methylenedioxymethamphetamine). Many drugs act on the aminergic system, the physiologically active biogenic amines.;

MeSH synonym : customized drugs; drugs, designer; drugs, customized; Designer Drug; Drug, Designer; Customized Drug; Drug, Customized;

MeSH annotation : D25-26 qualif; coord IM with specific drug or chemical (IM); do not confuse with DRUG DESIGN; coordinate with specific drug or chemical; do not confuse with DRUG DESIGN;

Wikipedia link : https://en.wikipedia.org/wiki/Designer drugs;

Is substance : O;

Details

Origin ID

D015198;

UMLS CUI

C0011684;

Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- analysis [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
False automatic mappings
- Do Not Substitute [NCIt concept]
- Nail-patella syndrome [OMIM Phenotype]
- drug design [IUPAC Term]
Indexing information
- (1H-indol-5-yl)propan-2-amine [MeSH Supplementary Concept]
- (1RS,3SR)-3-(4-(1,1-dimethyloctyl)-2-hydroxyphenyl)cyclohexan-1-ol [MeSH Supplementary Concept]
- 1-(4-methylphenyl)-2-pyrrolidin-1-ylhexan-1-one [MeSH Supplementary Concept]
- 1-(benzo(d)(1,3)dioxol-5-yl)butan-2-amine [MeSH Supplementary Concept]
- 2,17-dimethyl-17-hydroxyandrost-1-en-3-one [MeSH Supplementary Concept]
- 2,4,5-trimethoxyphenylisopropylamine [MeSH Supplementary Concept]
- 2-(2,5-dimethoxy-4-isopropylsulfanylphenyl)ethanamine [MeSH Supplementary Concept]
- 2-(ethylamino)-1-(4-methylphenyl)-1-pentanone [MeSH Supplementary Concept]
- 2-amino-1-(4-bromo-2,5-dimethoxyphenyl)ethan-1-one [MeSH Supplementary Concept]
- 2-ethylamino-1-(3,4-methylenedioxyphenyl)propan-1-one [MeSH Supplementary Concept]
- 2-methylamino-1-(3,4-methylenedioxyphenyl)butan-1-one [MeSH Supplementary Concept]
- 3-(2,4-dimethylphenyl)-2-methylquinazolin-4(3H)-one [MeSH Supplementary Concept]
- 3-bromomethcathinone [MeSH Supplementary Concept]
- 3-fluoromethcathinone [MeSH Supplementary Concept]
- 4'-fluoro-alpha-pyrrolidinobutyrophenone [MeSH Supplementary Concept]
- 4-fluoromethcathinone [MeSH Supplementary Concept]
- 4-iodo-2,5-dimethoxy-beta-phenethylamine [MeSH Supplementary Concept]
- 4-methylethcathinone [MeSH Supplementary Concept]
- 5-(2-aminopropyl)benzofuran [MeSH Supplementary Concept]
- N,N-dimethyl-2-phenylpropan-1-amine [MeSH Supplementary Concept]
- N-(1-(aminocarbonyl)-2-methylpropyl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide [MeSH Supplementary Concept]
- N-(1-phenylcyclohexyl)-2-ethoxyethanamine [MeSH Supplementary Concept]
- N-(1-phenylcyclohexyl)-2-methoxyethanamine [MeSH Supplementary Concept]
- N-(adamantan-1-yl)-1-(5-fluoropentyl)-1H-indole-3-carboxamide [MeSH Supplementary Concept]
- N-methyl-6-(2-aminopropyl)benzofuran [MeSH Supplementary Concept]
- alpha-methylfentanyl [MeSH Supplementary Concept]
- buphedrone [MeSH Supplementary Concept]
- dichlorodenafil [MeSH Supplementary Concept]
- mephedrone [MeSH Supplementary Concept]
- methoxydine [MeSH Supplementary Concept]
- napht-1-yl 1-(5-fluoropentyl)-1H-indole-3-carboxylate [MeSH Supplementary Concept]
- pentedrone [MeSH Supplementary Concept]
Metaterm(s)
- addictology [CISMeF Metaterm]
Record concept(s)
- designer drugs [MeSH concept]
Related MeSH Supplementary Concept(s)
- clonazolam [MeSH Supplementary Concept]
See also
- Illicit Drugs [MeSH Descriptor]
- drug design [MeSH Descriptor]
- substance-related disorders [MeSH Descriptor]
Semantic type(s)
- Hazardous or Poisonous Substance [UMLS semantic type]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients